Variable | Class1, n = 12 (high, stable) | Class2, n = 41 (high, moderate) | Class3, n = 20 (low, rapid) | Class4, n = 34 (medium, stable) | Group comparison |
---|---|---|---|---|---|
Follow-Up BMI | 17.56 (1.69) 1 | 19.32 (1.73) 2 | 18.03 (2.95) | 18.17 (1.49) | F(3,87) = 3.44, p = 0.02 a |
Follow-Up BMI > 18.5 | 4 /11 (36.4%) | 20/32 (62.3%) | 7/16 (43.8%) | 15/32 (46.9%) | X2 (3) = 3.18, p = 0.39 |
BMI change | 0.38 (1.68) 1 | 1.57 (1.80) 1 | 3.40 (2.95) 2 | 1.95 (1.55) | F(3,87) = 5.66, p < 0.001 |
Follow-Up EDE-Q | 2.50 (1.48) | 2.64 (1.88) | 2.28 (1.80) | 1.91 (1.41) | F(3,77) = 0.96, p = 0.42 |
Follow-Up EDE-Q < 2.8 | 6/10 (60.0%) | 19/29 (65.5%) | 9/14 (64.3%) | 23/29 (79.3%) | X2 (3) = 2.14, p = 0.59 |
EDE-Q change | −1.75 (1.31) | −1.51 (1.67) | − 1.30 (1.75) | −1.44 (1.24) | F(3,69) = 0.19, p = 0.90 |
Completed treatment | 11/12 (91.7%) | 28/41 (68.3%) | 13/20 (65.0%) | 29/34 (85.3%) | Fisher’s Exact = 5.61, p = 0.14 |
Intensive treatment b | – | 2/41 (4.9%) | 4/20 (20.0%) | 3/34 (8.8%) | Fisher’s Exact = 0.18, p = 0.15 |
Remission at Follow-up | 1/10 (10.0%) | 13/30 (43.3%) | 5/16 (31.3%) | 10/30 (33.3%) | Fisher’s Exact = 3.84, p = 0.28 |